Myelodysplastic Syndrome

Print

VIDEO04:00

Medical oncologist Virginia Klimek discusses a multicenter Phase III randomized clinical trial for MDS patients with symptomatic anemia.

We provide comprehensive care to more than 100 individuals newly diagnosed with myelodysplastic syndromes annually. In addition to our designation as a Center of Excellence by the Myelodysplastic Syndromes Foundation, we are recognized as a leading institution for stem cell transplantation for MDS. We direct numerous clinical trials of investigational agents and innovative treatment approaches.